Markes International (Bridgend, UK) has celebrated its silver anniversary with 25 years since its founding in 1997.
Markes International (Bridgend, UK) has celebrated its silver anniversary with 25 years since its founding in 1997. Since that time the company has grown to operate globally through an international network of distributors and its own technical centres in the USA, China, and Germany.
The company was founded by Elizabeth Woolfenden and Alun Cole specifically to develop more efficient thermal desorption (TD) instruments than those available at the time. Thanks to its trap-based focusing technology and associated patents, Markes is still one of the world’s foremost manufacturers in its field, and its instruments, along with the company itself, have won numerous awards over the years, including three separate Queen’s Awards: two for International Trade in 2015 and 2019, as well as one for Innovation in 2019.
To celebrate its 25 successful years, the company laid on a day of social activities for all staff in its UK headquarters. “It was fitting to share the company’s landmark achievement with all staff, and as a team, we are all very much looking forward to the next 25 years ahead,” said Markes’ co-founder Alun Cole.
“When we founded the company in 1997, we had no doubts it would be a success because we knew that the technology we were developing was going to be ground-breaking in the world of analytical instrumentation. Needless to say, we’re delighted that 25 years later, we’re not only still leading the field in terms of innovation but also continuing to thrive and grow,” continued Cole.
From the LCGC team, we would like to congratulate Markes International on 25 successful years and wish them all the best in the next!
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.